ADVENT TECHNOLOGIES HOLDINGS (ADN)
US00788A2042 - Common Stock
ADN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 89 industry peers in the Electrical Equipment industry. ADN may be in some trouble as it scores bad on both profitability and health. ADN shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year ADN has reported negative net income.
In the past year ADN has reported a negative cash flow from operations.
In the past 5 years ADN always reported negative net income.
In the past 5 years ADN always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of ADN (-405.09%) is worse than 94.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -405.09% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-100.37%
ROA(5y)-96.93%
ROE(3y)-220.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ADN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ADN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ADN has more shares outstanding than it did 1 year ago.
ADN has more shares outstanding than it did 5 years ago.
There is no outstanding debt for ADN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of -29.92, we must say that ADN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ADN (-29.92) is worse than 93.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -29.92 |
ROIC/WACCN/A
WACC11.05%
2.3 Liquidity
A Current Ratio of 0.44 indicates that ADN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.44, ADN is doing worse than 94.32% of the companies in the same industry.
A Quick Ratio of 0.31 indicates that ADN may have some problems paying its short term obligations.
With a Quick ratio value of 0.31, ADN is not doing good in the industry: 93.18% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.44 | ||
| Quick Ratio | 0.31 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 51.72% over the past year.
The Revenue has grown by 9.01% in the past year. This is quite good.
Measured over the past years, ADN shows a very strong growth in Revenue. The Revenue has been growing by 67.03% on average per year.
EPS 1Y (TTM)51.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.09%
Revenue 1Y (TTM)9.01%
Revenue growth 3Y76.57%
Revenue growth 5Y67.03%
Sales Q2Q%-27.48%
3.2 Future
ADN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.75% yearly.
Based on estimates for the next years, ADN will show a very strong growth in Revenue. The Revenue will grow by 633.14% on average per year.
EPS Next Y98.1%
EPS Next 2Y44.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2705.94%
Revenue Next 2Y633.14%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
ADN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ADN is valuated quite expensively with a Price/Forward Earnings ratio of 60.10.
Based on the Price/Forward Earnings ratio, ADN is valued a bit cheaper than the industry average as 65.91% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ADN to the average of the S&P500 Index (23.73), we can say ADN is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 60.1 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ADN's earnings are expected to grow with 44.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.75%
EPS Next 3YN/A
5. Dividend
5.1 Amount
ADN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ADVENT TECHNOLOGIES HOLDINGS
NASDAQ:ADN (1/6/2025, 4:05:54 PM)
After market: 6.22 +0.15 (+2.47%)6.07
+0.7 (+13.04%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners3.5%
Inst Owner Change0%
Ins Owners15.94%
Ins Owner Change0%
Market Cap16.02M
Analysts45
Price TargetN/A
Short Float %6.66%
Short Ratio0.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 60.1 | ||
| P/S | 2.28 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-25.82
EYN/A
EPS(NY)0.1
Fwd EY1.66%
FCF(TTM)-7.23
FCFYN/A
OCF(TTM)-6.83
OCFYN/A
SpS2.66
BVpS-1.09
TBVpS-1.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -405.09% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-100.37%
ROA(5y)-96.93%
ROE(3y)-220.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 28.82% | ||
| Cap/Sales | 14.96% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.44 | ||
| Quick Ratio | 0.31 | ||
| Altman-Z | -29.92 |
F-Score2
WACC11.05%
ROIC/WACCN/A
Cap/Depr(3y)197.26%
Cap/Depr(5y)268.79%
Cap/Sales(3y)91.22%
Cap/Sales(5y)58.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.09%
EPS Next Y98.1%
EPS Next 2Y44.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.01%
Revenue growth 3Y76.57%
Revenue growth 5Y67.03%
Sales Q2Q%-27.48%
Revenue Next Year2705.94%
Revenue Next 2Y633.14%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.18%
OCF growth 3YN/A
OCF growth 5YN/A